Chemoinformaics analysis of 21-hydroxyfriedelan-3-one
| Molecular Weight | 442.728 | nRot | 1 |
| Heavy Atom Molecular Weight | 392.328 | nRig | 27 |
| Exact Molecular Weight | 442.381 | nRing | 5 |
| Solubility: LogS | -5.823 | nHRing | 0 |
| Solubility: LogP | 5.982 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 85.0436 |
| nHD | 1 | BPOL | 51.0284 |
| QED | 0.458 |
| Synth | 4.939 |
| Natural Product Likeliness | 2.713 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.031 |
| Pgp-sub | 0 |
| HIA | 0.029 |
| CACO-2 | -5.147 |
| MDCK | 0.00000664 |
| BBB | 0.632 |
| PPB | 0.97595 |
| VDSS | 1.439 |
| FU | 0.0195999 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.678 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.96 |
| CYP2c9-inh | 0.068 |
| CYP2c9-sub | 0.108 |
| CYP2d6-inh | 0.043 |
| CYP2d6-sub | 0.411 |
| CYP3a4-inh | 0.219 |
| CYP3a4-sub | 0.628 |
| CL | 19.204 |
| T12 | 0.074 |
| hERG | 0.013 |
| Ames | 0.034 |
| ROA | 0.164 |
| SkinSen | 0.303 |
| Carcinogencity | 0.012 |
| EI | 0.181 |
| Respiratory | 0.872 |
| NR-Aromatase | 0.727 |
| Antiviral | No |
| Prediction | 0.753992 |